Metraipolis › archive › dc_acddc44fd995

The efficacy of DPP IV inhibitors as adjunct therapy for patients with auto-immune Diabetes: A systematic review and meta-analysis — Europe PMC PMID:41026724

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41026724
DOI
10.1371/journal.pone.0332191
License (as archived)
solo-consultazione
Archived
2026-11-09T17:04:06.903Z
SHA-256 of the archived text
46114d54defeeb6cc0e92d09ebae81fc218e34d61f420272cb4d33faad633a6e
Stable URL of this page
https://metraipolis.com/documento/dc_acddc44fd995

How to cite

The efficacy of DPP IV inhibitors as adjunct therapy for patients with auto-immune Diabetes: A systematic review and meta-analysis — Europe PMC PMID:41026724 — Europe PMC (en), https://europepmc.org/article/MED/41026724 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_acddc44fd995 (Metraipolis archive dc_acddc44fd995, sha256 46114d54defeeb6cc0e92d09ebae81fc218e34d61f420272cb4d33faad633a6e)
BibTeX
@misc{dcacddc44fd995,
  title = {The efficacy of DPP IV inhibitors as adjunct therapy for patients with auto-immune Diabetes: A systematic review and meta-analysis — Europe PMC PMID:41026724},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41026724},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_acddc44fd995; sha256 46114d54defeeb6cc0e92d09ebae81fc218e34d61f420272cb4d33faad633a6e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41026724. Agents can read the archived copy with the MCP tool read_document.